Target intelligence / Profile preview

Purinergic receptor P2X5 (P2X5)

Target
P2X5
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, ATP-gated cation channel, Purinergic receptor
01

Overview

Purinergic receptor P2X5 is a member of the P2X family of ligand-gated ion channels that respond to extracellular ATP by opening a channel permeable to sodium, potassium, calcium, and (uniquely among P2X channels) chloride ions. In humans, the receptor is encoded by the P2RX5 gene, but most individuals express nonfunctional truncated isoforms due to exon skipping, which disrupts normal ion channel assembly and function. In functional animal models, P2X5 plays important roles in inflammatory responses, especially in osteoclast maturation, multinucleation, and ATP-dependent inflammasome activation, contributing to cytokine (IL-1β) release and bone homeostasis. P2X5 is also expressed by various mammalian cell types, suggesting possible functions in the nervous system, muscle, immune, and endocrine cells, but its physiological roles remain under investigation, particularly in humans where full-length functional P2X5 is rare.

Other names
P2RX5P2X purinoceptor 5P2X5P2X5FLLRH-1ATP receptorPurinergic receptorP2X5RATP receptor subunitIonotropic ATP receptor P2X5Lymphoid-restricted histocompatibility antigen-1Purinergic receptor P2X, ligand-gated ion channel 5
02

Mechanism of action

Therapeutic targeting would likely involve inhibition or modulation of ATP-gated channel activity, affecting downstream inflammasome activation and cytokine release

03

Biological functions

Signal transductionCalcium fluxCell fusion/multinucleationInflammasome activationImmune responseRegulation of inflammatory cytokine (IL-1β) productionPossible role in bone homeostasis
04

Disease associations

InflammationBone loss-related diseasesCystinosisCanavan diseaseMay be relevant in other inflammatory or bone homeostasis disorders
05

Safety considerations

Truncated human isoforms are often nonfunctional due to exon skipping, which may limit therapeutic relevance or alter physiological outcomesLack of functional protein in most human tissues (because of common polymorphisms) complicates translational targeting and efficacy monitoring.
06

Interacting drugs

No specific drugs directly targeting P2X5 are currently approved or widely documented
07

Biomarkers

Expression of P2X5 (or its functional effects on IL-1β release) may serve as a biomarker for inflammatory bone loss conditions and osteoclast hyper-multinucleation in experimental systems

Beyond the preview

Go deeper on Purinergic receptor P2X5 (P2X5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purinergic receptor P2X5 (P2X5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call